Signaturefd LLC raised its position in shares of National Research Co. (NASDAQ:NRC – Free Report) by 613.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,173 shares of the company’s stock after purchasing an additional 3,588 shares during the quarter. Signaturefd LLC’s holdings in National Research were worth $74,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of NRC. PNC Financial Services Group Inc. raised its holdings in shares of National Research by 2,250.8% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,528 shares of the company’s stock worth $27,000 after purchasing an additional 1,463 shares in the last quarter. FMR LLC increased its holdings in shares of National Research by 397.3% in the third quarter. FMR LLC now owns 2,944 shares of the company’s stock valued at $67,000 after buying an additional 2,352 shares in the last quarter. Point72 Asset Management L.P. bought a new stake in shares of National Research during the 3rd quarter worth $88,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of National Research in the 3rd quarter worth $96,000. Finally, SG Americas Securities LLC raised its position in shares of National Research by 35.0% during the fourth quarter. SG Americas Securities LLC now owns 7,298 shares of the company’s stock worth $129,000 after purchasing an additional 1,893 shares during the period. 47.26% of the stock is currently owned by institutional investors and hedge funds.
National Research Trading Up 1.7 %
Shares of NASDAQ NRC opened at $14.68 on Tuesday. The business has a fifty day simple moving average of $16.18 and a 200-day simple moving average of $18.24. The company has a market cap of $336.85 million, a price-to-earnings ratio of 13.98 and a beta of 0.47. National Research Co. has a 12 month low of $13.74 and a 12 month high of $40.14. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30.
National Research Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 3.27%. National Research’s dividend payout ratio (DPR) is presently 45.71%.
National Research Profile
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Stories
- Five stocks we like better than National Research
- Why Are These Companies Considered Blue Chips?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Profitably Trade Stocks at 52-Week Highs
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Using the MarketBeat Dividend Tax Calculator
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.